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Abstract: Few studies have analyzed the potential of biophysical parameters as markers of cardiac
remodeling post-myocardial infarction (MI), particularly in human hearts. Fourier transform infrared
spectroscopy (FTIR) illustrates the overall changes in proteins, nucleic acids and lipids in a single
signature. The aim of this work was to define the FTIR and lipidomic pattern for human left
ventricular remodeling post-MI. A total of nine explanted hearts from ischemic cardiomyopathy
patients were collected. Samples from the right ventricle (RV), left ventricle (LV) and infarcted left
ventricle (LV INF) were subjected to biophysical (FTIR and differential scanning calorimetry, DSC)
and lipidomic (liquid chromatography–high-resolution mass spectrometry, LC–HRMS) studies. FTIR
evidenced deep alterations in the myofibers, extracellular matrix proteins, and the hydric response
of the LV INF compared to the RV or LV from the same subject. The lipid and esterified lipid FTIR
bands were enhanced in LV INF, and both lipid indicators were tightly and positively correlated
with remodeling markers such as collagen, lactate, polysaccharides, and glycogen in these samples.
Lipidomic analysis revealed an increase in several species of sphingomyelin (SM), hexosylceramide
(HexCer), and cholesteryl esters combined with a decrease in glycerophospholipids in the infarcted
tissue. Our results validate FTIR indicators and several species of lipids as useful markers of left
ventricular remodeling post-MI in humans.
Keywords: biophysical markers; cardiac remodeling post-MI; lipidomics; Fourier transform infrared
spectroscopy; heart failure
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1. Introduction
Ischemic heart disease is the primary cause of death in Western countries, and myocardial
infarction occupies about 50% of deaths in this group. Despite the important improvements in the
management of myocardial infarction, adverse left ventricular remodeling, which occurs in up to
30% of cases following ST-segment elevation myocardial infarction (STEMI), is strongly associated
with poor patient outcomes. Chronic left ventricular remodeling (LVR) is, apart from infarct size and
infarct wound healing, the primary determinant of heart failure post-myocardial infarction (MI) [1,2].
Adverse LVR after MI involves crucial changes in the composition and organization of the extracellular
matrix (ECM) [3].
The location, size and shape of MI is commonly determined by imaging techniques at the
clinical level or by histopathology at the experimental level. Detailed information about the chemical
composition and physical structure of infarct zones post-MI remains limited. Previous studies from our
group have shown that Fourier transform infrared (FTIR) spectroscopy has the potential to highlight
the main alterations that occur in cardiac remodeling in a post-MI mice model [4], as well as in a pig
model of tachycardia-induced dilated cardiomyopathy [5]. The FTIR spectra of freeze-dried mice’s left
ventricles showed amides I and II to be the major absorptions bands. Collagen possesses a specific band
at 1338 cm−1 [6] that can be used to compile a collagen/protein indicator. Finally, the sub-resolution of
the FTIR spectra determined by Fourier self-deconvolution (FSD) and the second derivative method in
the amide I/II zone is useful for determining the secondary structures of proteins [7]. In a mice model,
we showed that an increase in the collagen indicator in the infarcted tissue is associated with the
predominance of the triple helical conformation of proteins, evidencing a deep remodeling of this zone.
In addition to structural remodeling, infarcted tissue undergoes what is called “metabolic
remodeling”, which includes a set of metabolic changes that occur in the cardiac tissue exposed to
ischemia. These metabolic changes include partial insulin resistance, associated with reduced fatty
acid oxidation and impaired mitochondrial biogenesis [8,9], downregulation of metabolic genes [10],
and upregulation of lipoprotein receptors that contribute to increasing the intracellular lipids in
cardiomyocytes [11–14]. A high prevalence of myocardial lipids has been found in areas of chronic
MI in humans [15]. Patients with cardiac lipid deposition had larger infarctions, as well as decreased
wall thickening and impaired endocardial wall motion. The hydrolysis of lipid species such as
phospholipids in the membrane of cardiomyocytes during ischemic processes is intimately linked
to the pathogenesis of myocardial infarction [16,17]. Clinical studies have identified new circulating
metabolites that are derived from phospholipidic metabolism in serum and are useful as potential new
biomarkers in cardiac remodeling post-MI [18–22]. To the best of our knowledge, only one lipidomic
study has been performed in cardiac infarcted tissues, and was developed using pigs [13].
The objective of the current investigation was to identify conformational, biophysical, and lipidomic
alterations that are useful as biomarkers of cardiac adverse remodeling in human infarcted hearts.
2. Materials and Methods
2.1. Collection of Human Samples
A total of 9 explanted human hearts from ischemic cardiomyopathy patients were collected and
immediately processed. These hearts were from patients undergoing cardiac transplantation in the
Department of Cardiology. The myocardial samples from the explanted hearts were collected in
the Department of Pathology (both departments from Santa Creu I Sant Pau Hospital, Barcelona).
Clinical data, electrocardiograms, Doppler echocardiography, hemodynamic studies, and coronary
angiography were available for all patients. All patients were functionally classified according to
the New York Heart Association (NYHA) criteria and received medical treatment according to the
guidelines of the European Society of Cardiology [23] using diuretics 89%, angiotensin-converting enzyme
inhibitors 86%, β-blockers 48%, aldosterone antagonists 71%, digoxin 49% and statins 82% (Table 1).
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Table 1. Clinical and echocardiographic characteristics from whom explanted ischemic hearts
were obtained.
ICM (n = 9)
Age (years) 57.67 ± 12.02
Gender male (%) 78
Prior Hypertension (%) 44
Diabetes mellitus (%) 11
Dislipemia (%) 75
Perfusion abnormalities * (%) 72
Echo-Doppler study
Ejection fraction (%) 29.88 ± 8.90
Intraventricular septum in diastole (mm) 11.63 ± 4.63
Left ventricular posterior wall in diastole (mm) 9.53 ± 0.75
Left ventricular end-diastolic diameter (mm) 60.38 ± 14.15
Left ventricular end-systolic diameter (mm) 56.25 ± 2.79
Treatment (%)
Diuretics 89





ICM, ischemic cardiomyopathy; * the patients with perfusion abnormalities were considered those subjected to
coronary interventions (i.e. by-pass, angioplasty, stents and others).
Hearts were weighed and measured, and samples from the right ventricle (RV) (n = 9), left ventricle
(LV) (n = 9), and infarcted left ventricle (LV INF) (n = 9) were excised and frozen at −80 ◦C for
immunohistochemical, biophysical and lipidomic studies. The project was approved by the local Ethics
Committee of Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, and was conducted in accordance
with the guidelines of the Declaration of Helsinki. All patients gave written informed consent that was
obtained according to our institutional guidelines.
2.2. Tissue Homogenization and Preparation of the Samples for the Different Studies
One portion of collected tissue was embedded in optimal cutting temperature compound (OCT)
and used for immunohistochemical studies. Other portion was frozen under N2, pulverized using
a mortar and a pestle in liquid nitrogen and used for the biophysical studies. A 5 mg aliquot was
freeze dried and used for vibrational characterization and a 25 mg aliquot was used for differential
scanning calorimetry (DSC). Another aliquot of pulverized tissue (500 µg) was dissolved in a lysis
buffer (Tris-HCl 1 M, KCl 1 M, and protease inhibitors 1 µg/mL) and used for the lipidomic studies.
2.3. Immunohistochemical Analysis
Myocardial collagen was immunohistochemically assessed by Sirius Red Staining as
previously described [24].
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2.4. Vibrational Characterization
The Fourier transform infrared spectroscopy/attenuated total reflectance (FTIR/ATR) spectra of
the freeze-dried tissues were acquired using a Nicolet 5700 FTIR instrument (Thermo Fisher Scientific,
Waltham, MA, USA) equipped with an ATR device with a KBr beam splitter and an MCT/B detector.
The ATR accessory used was a Smart Orbit with a type IIA diamond crystal (refractive index 2.4,
Thermo Fisher Scientific, Waltham, MA, USA). Samples were directly deposited on the entire active
surface of the crystal and gently compressed using a Teflon tip to ensure good contact. For each sample,
80 interferograms were recorded in the 4000–450 cm−1 region, co-added and Fourier-transformed to
generate an average spectrum of the segmented heart part with a nominal resolution of 1 cm−1 using
Omnic 8.0 (Thermo Fisher Scientific, Waltham, MA, USA). The single-beam background spectrum was
collected from the clean diamond crystal before each experiment, and this background was subtracted
from the spectra.
To circumvent the attenuation of penetration depth in the samples at large wave numbers in
the ATR mode, spectra were subjected to advanced ATR correction. Then, the spectra were baseline
corrected and normalized using the maximum of the amide II peak. These spectra were subsequently
used to calculate the integrated band intensities and their ratios. For semi-quantitative comparison
between groups, the areas of the different absorption bands were computed from the individual
spectrum of each tissue, and the appropriate ratio of areas was used according to the literature data
in trans-reflectance or ATR mode [25,26]. Second derivatives were used to enhance the chemical
information present in the overlapping infrared absorption bands of the spectra. All spectra processing
was performed using Omnic 8.0. The spectra presented for each group were calculated by averaging
the spectra of all samples within each group.
2.5. Differential Scanning Calorimetry
Calorimetric analyses were performed using a DSC Pyris calorimeter (Perkin Elmer, Waltham,
MA). The calorimeter was calibrated using Hg and In resulting in a temperature accuracy of 0.1 ◦C and
an enthalpy accuracy of 0.2 J/g. Fresh samples, 5–10 mg in weight, were set into hermetic aluminum
pans and equilibrated at the initial temperature for 5 min before cooling to −100 ◦C at 10 ◦C/min.
Then, the thermograms were recorded during heating at 10 ◦C/min until reaching 90 ◦C. After the DSC
measurements were performed, the pans were reweighed to check that they had been correctly sealed.
2.6. Lipidomic Analysis of the Heart
Phospholipids (PLs) and sphingolipids (SLs extracts) were prepared and analyzed using the
following protocols previously described [27,28], with minor modifications.
2.6.1. Phospholipids and Neutral Lipids
A 750 µL methanol–chloroform (1:2, v/v) solution containing standards was transferred to
borosilicate glass test tubes with Teflon caps, and 0.25 mL methanol and 0.5 mL chloroform were
subsequently added. This mixture was fortified with the internal standards of lipids (200 pmol
each). The following standards were added to myocardial samples: 16:0 D31_18:1 phosphocholine,
16:0 D31_18:1 phosphoethanolamine, 16:0 D31-18:1 phosphoserine, 17:0 lyso-phosphocholine,
17:1 lyso-phosphoethanolamine, 17:1 lyso-phosphoserine, 17:0/17:0/17:0 triacylglycerol, and C17:0
cholesteryl ester; 0.2 nmol of each standard (from Avanti Polar Lipids). The samples were vortexed and
sonicated until they appeared dispersed and were then incubated at 48 ◦C overnight. The solvent was
removed using a Speed Vac Savant SPD131DDA (Thermo Scientific). Lipids were solubilized in 0.5 mL
of methanol and transferred to 1.5 mL Eppendorf tubes and evaporated again. The samples were
resuspended in 150 µL of methanol. The tubes were centrifuged at 13,000× g for 3 min, and 130 µL
of the supernatants was transferred to ultra-performance liquid chromatography (UPLC) vials for
injection and analysis.
Biomolecules 2020, 10, 1471 5 of 20
2.6.2. Sphingolipids
A 750 µL methanol–chloroform (2:1, v/v) solution containing internal standards (N-dodecanoylsphingosine,
N-dodecanoylglucosylsphingosine, N-dodecanoylsphingosylphosphorylcholine, and C17-sphinganine,
0.2 nmol each, from Avanti Polar Lipids) was added to the myocardial samples. The samples were
extracted at 48 ◦C overnight and cooled. Then, 75 µL of 1 M KOH in methanol was added to saponify
phospholipids and prevent their possible interference in the detection of sphingolipids, and the mixture
was incubated for 2 h at 37 ◦C. Following the addition of 75 µL of 1 M acetic acid, the samples were
evaporated to dryness, and stored at −20 ◦C until analysis. Before analysis, 150 µL of methanol was
added to the samples. Then, the samples were centrifuged at 13,000× g for 5 min, and 130 µL of the
supernatant was transferred to a new vial and injected.
2.6.3. UPLC Coupled to HRMS Analysis
Ultra Performance Liquid chromatography (UPLC) coupled to high-resolution mass spectrometry
(HRMS) analysis was performed using an Acquity ultra-high-performance liquid chromatography
(UHPLC) system (Waters, USA) connected to a Time of Flight (LCT Premier XE) Detector. The full-scan
spectra from 50 to 1800 Da were acquired, and individual spectra were summed to produce data points
each being 0.2 s. Mass accuracy at a resolving power of 10,000 and reproducibility were maintained
using an independent reference spray via LockSpray interference.
Lipid extracts were injected onto an Acquity UPLC BEH C8 column (1.7 µm particle size, 100 mm
× 2.1 mm, Waters Ireland) at a flow rate of 0.3 mL/min and a column temperature of 30 ◦C. The mobile
phases were water with 2 mM of ammonium formate and 0.2% of formic acid (A) and methanol with
2 mM of ammonium formate and 0.2% of formic acid (B).The UPLC conditions were programmed as
follows: 0.0 min_80% B; 3 min_90% B (linear gradient); 6 min_90% B (isocratic); 15 min_99% B (linear
gradient); 18 min_99% B (isocratic); 20 min_80% B (linear gradient); 22 min_80% B (isocratic).
Positive identification of compounds was based on the accurate mass measurement and
its LC retention time, compared with that of a standard (<2%). Selected ions for SLs and
glycerophospholipids correspond to [M + H]+, whereas ammonia adduct were used for neutral lipids
(Table S1). The ceramide (Cer) standards used were N-palmitoyl-sphingosine, N-stearoyl-sphingosine,
N-lignoceroyl-sphingosine and N-nervonoyl-sphingosine. The sphingomyelin (SM) standards
used were N-palmitoylsphingosyl phosphorylcholine, egg SMs (predominant C16:0SM) and
brain SMs (C18:0SM, C24:0SM and C24:1SM in known percentages). The glucosylceramide
standard used was N-palmitoylglucosylsphingosine. The lactosylceramide standard used was
N-palmitoyl-lactosylsphingosine. The diacylphospholipid standards used were 1,2-dipalmitoyl
-snglycero- 3-phosphocholine, 1-palmitoyl-2-oleoyl-sn-glycero- 3-phosphocholine, 1-palmitoyl-2-oleoyl
-sn-glycero-3-phosphoethanolamine and 1-palmitoyl-2-oleoyl-sn-glycero- 3-phospho-L-serine.
The lysophospholipid standards used were 1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine,
1-oleoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine and 1-oleoyl-2-hydroxy-sn-glycero-3-phospho
-L-serine. The triacylglycerol standard used was 1,2,3-tri-(9Z-octadecenoyl)-glycerol. The cholesteryl
ester standard used was cholesteryl cis-9-octadecenoate. When authentic standards were not available,
identification was achieved based on their accurate mass measurement, elemental composition,
calculated mass, error, double-bond equivalents and retention times. Quantification was carried
out using the extracted ion chromatogram of each compound, obtained with a mass chromatogram
absolute window value of 0.05 Da. As an example, representative ion chromatograms for sphingolipids
(Figure S1), glycerophospholipids (Figures S2 and S3) and neutral lipids (Figure S4) of the right,
left and infarcted left ventricle from the same patient are shown. The linear dynamic range was
determined by injecting mixtures of internal and natural standards indicated above. If values were
above the linear dynamic range, samples were diluted and analyzed again. Since standards for all
identified lipids were not available, the amounts of lipids are given as pmol equivalents relative to
each specific standard (Table S1).
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Sphingolipids (Cer: ceramide; SM: sphingomyelin; CDH: Ceramide dihexoside; HexCer:
hexosylceramides), glycerophospholipids (PC: phosphatidylcholine; LPC: lysophosphatidylcholine;
PE: phosphatidylethanolamine; LPE: lysophosphatidylethanolamine; PS: phosphatidylserine; LPS:
lysophosphatidylserine, PG: phosphatidylglycerol), and neutral lipids (TAG: triacylglycerol; CE:
cholesteryl esters; free cholesterol: FC) were detected. All glycerophospholipid and neutral lipid
species were annotated using the “lipid subclass” and “C followed by the total fatty acid (FA) chain
length:total number of unsaturated bonds” (e.g., PC (32:2)).
2.7. Statistical Analysis
Variables were compared two by two among the 3 groups (RV, LV and LV INF) using Student’s
t-test or a Mann–Whitney U test for paired samples (myocardial samples were from the same
patient), respectively, depending on whether the variables were normal. Normality was tested with a
Shapiro–Wilk and Lilliefors test. p values were adjusted with Bonferroni’s correction, we performed
3 comparisons for each variable.
The correlations between variables were studied in each group using Pearson’s correlation.
p values were adjusted with Bonferroni’s correction because we tested the correlation among all
lipidomic and biophysical variables. p < 0.05 was considered statistically significant.
Lipidomic variables whose differences were significant in some of the study groups were
represented in a heatmap. Each variable was represented as a logarithm of the quotient of the group
mean and the mean value in all groups.
Statistical power was calculated afterwards as few lipidomic studies in human hearts have
been performed until now and it was difficult to estimate the effect size in some lipidomic variables.
Assuming the differences obtained in the significant variables as the real effect size, we obtained a
range of values of statistical power between 0.64 and 0.98 in differential analysis and a range between
0.79 and 1 in correlation analysis.
All data analyses were performed using R 4.0.2 software [29].
3. Results
3.1. Identification of the Main FTIR Bands in the Human Heart
To compare the spectral signature of the human heart with previous data collected from animal
hearts [4,5], the average FTIR spectra of mice, pig, and human right ventricles were superimposed
(Figure 1). Table S2 summarizes the different FTIR absorption bands detected in human compared to
pig and mice right ventricles, as well as their assignments, according to previously published data in
transmission or ATR mode [5,6,30–37]. The major absorption bands in these spectra were the amide
A, the amide I, and the amide II, which are mainly associated with proteins in freeze-dried tissues.
Since Amide A is located in the large wave number zone where FTIR-ATR is not the more appropriate
mode, the intensity of this mode has not been used for further semi-quantitative analysis. The primary
ventricular proteins are cardiomyocyte myofibrillar (myosin, α-actin) and sarcoplasmic proteins and
the structural proteins of the extracellular matrix (ECM), i.e., fibrillar collagens I and III. Among these
different vibrations, the 1338 cm−1 band (wagging of the proline side chain) [6,25,36] corresponds to a
specific signature of the structural proteins of the ECM since it is the only one that does not overlap
with absorption or other components, e.g., DNA, lipids, or proteoglycans. As shown in Figure 1,
the spectral signatures of the structural proteins of the ECM and the myofibers from mice, pigs and
humans are very similar.
Biomolecules 2020, 10, 1471 7 of 20Biomolecules 2020, 10, 1471 7 of 20 
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The complex FTIR spectra of the ventricles also include lipids with their classic markers at 
2800–3000 cm–1 (especially the CH2 stretching of long hydrocarbon chains) (Figure 1A) and at 
1475–1450 cm–1 (CH2 scissoring and CH3 bending) (Figure 1B). These lipids are mainly 
phospholipids of the plasmatic membranes, confirmed by the presence of the C=O stretching of ester 
groups, the CO-O-C and PO2- stretching bands, triglycerides, cholesteryl esters, free cholesterol and 
free fatty acids (C=O stretching at 1712 cm–1 and COO- stretching at 1392 cm–1). Unsaturated lipids 
are specifically marked by the 3013 cm–1 band. 
Where the band position of the lipids is quasi-identical among the three species, the lipid 
vibrational response is more intense in human ventricles (for both the ν(CH2) and ν(C=O) bands) 
than in pig and mice ventricles. 
Finally, as shown in Figure 1C, other ventricular components contributed to this complex 
vibrational response including DNA, specifically at 974 cm–1 [37]; proteoglycans (contributing to the 
1079 cm–1 band and the overlapping 1226 cm–1 band); glycogen; and other polysaccharides 
(1200–1000 cm–1). The composite (1240–1100 cm–1) zone is subjected to fine differences due to 
disparities in the nature or proportion of these components among the three compared species. 
3.2. Characterization of the Human Heart Lipidome 
UPLC–HRMS analysis electrospray ionization mass spectrometry revealed 44 species of 
sphingolipids, 60 species of glycerophospholipids, and 60 species of neutral lipids in the human 
heart. The relative amount of each lipid in the whole family was expressed as the percentage of each 
lipid area compared to the total number of lipids of the same family in the right and left ventricles 
(Figures S5–S7).  
The relative abundance of the species present for each particular lipid among the family of 
sphingolipids in the human heart is also shown (Figure S5A–E). The most abundant sphingolipid in 
the human heart is sphingomyelin d18:1 (SM, 88.53%), particularly the species with long fatty acid 
Figure 1. Averaged Fourier transform infrared spectroscopy (FTIR) spectra of the right ventricles from
the mice, pig, and human samples. Line graphs showing the 3600–2800 cm−1 (A), 1800–1350 cm−1 (B),
and 1350–900 cm−1 (C) spectral regions of mice, pig, and human right ventricles.
The complex FTIR spectra of the ventricles also include lipids with their classic markers at
2800–3000 cm−1 (especially the CH2 stretching of long hydrocarbon chains) (Figure 1A) and at
1475–1450 cm−1 (CH2 scissoring and CH3 bending) (Figure 1B). These lipids are mainly phospholipids
of the plasmatic membranes, confirmed by the presence of the C=O stretching of ester groups,
the CO-O-C and PO2− stretching bands, triglycerides, cholesteryl esters, free cholesterol and free
fatty acids (C=O stretching at 1712 cm−1 and COO- stretching at 1392 cm−1). Unsaturated lipids are
specifically marked by the 3013 cm−1 band.
Where the band position of the lipids is quasi-identical among the three species, the lipid
vibrational response is more intense in human ventricles (for both the ν(CH2) and ν(C=O) bands) than
in pig and mice ventricles.
Finally, as shown in Figure 1C, other ventricular components contributed to this complex
vibrational response including DNA, specifically at 974 cm−1 [37]; proteoglycans (contributing to
the 1079 cm−1 band and the overlapping 1226 cm−1 band); glycogen; and other polysaccharides
(1200–1000 cm−1). The composite (1240–1100 cm−1) zone is subjected to fine differences due to
disparities in the nature or proportion of these components among the three compared species.
3.2. Characterization of the Human Heart Lipidome
UPLC–HRMS analysis electrospray ionization mass spectrometry revealed 44 species of
sphingolipids, 60 species of glycerophospholipids, and 60 species of neutral lipids in the human heart.
The relative amount of each lipid in the whole family was expressed as the percentage of each lipid area
compared to the total number of lipids of the same family in the right and left ventricles (Figures S5–S7).
The relative abundance of the species present for each particular lipid among the family of
sphingolipids in the human heart is also shown (Figure S5A–E). The most abundant sphingolipid in
the human heart is sphingomyelin d18:1 (SM, 88.53%), particularly the species with long fatty acid
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chains (from 14 to 18 C) (Figure S5A). Minor species include ceramide d18:1 (Cer, 6.94%) (Figure S5B),
followed by dihydrosphingomyelin d18:0 (dhSM, 3.56%) (Figure S5C), hexosylceramide (d18:1) (HexCer,
0.58%) (Figure S5D) and ceramide dihexoside (18:1) (CDH, 0.39%) (Figure S5E). CDH (d18:14:0) was
significantly higher in LV than in RV (p = 0.045) (Figure S5E).
The most abundant glycerophospholipids in human cardiac tissue are phosphatidylcholine
(PC, 75.24%), mainly species with long fatty acid (FA) chains (from 32 to 38 C) (Figure S6A);
followed by phosphatidylserine (PS, 8.43%) (Figure S6B); lyso-phosphatidylcholine (LPC, 6.62%)
(Figure S6C), phosphatidylethanolamine (PE, 4.96%) (Figure S6D), lyso-phosphatidylethanolamine
(LPE, 2.88%) (Figure S6E), lyso- phosphatidylserine (LPS, 1.12%) (Figure S6F) and phosphatidylglycerol
(PG, 0.76%) (Figure S6G).
Finally, as shown in Figure S7, the neutral lipids in the human hearts contain a high percentage of
triglycerides (TAG, 97.06%) (Figure S7A). Several TAG species with longer unsaturated chains of fatty
acids (FAs), decreased in the LV compared to the RV. These TAG species were C53:2 (p = 0.041), C54:1
(p = 0.036), and C54:2 (p = 0.033). The decrease in TAG in human LV compared to RV was previously
reported in a porcine model [5] and likely reflects a higher effort and more energetic consumption of LV.
Most of the cholesterol was found in the form of free cholesterol (FC, 2.03%) (Figure S7B), with a minor
proportion found as cholesteryl esters (CE, 0.90%) (Figure S7C). There were no statistically significant
differences in FC or CE between RV and LV.
3.3. Identification of the Alterations of the FTIR Bands Related to Myofibers and Structural Extracellular
Matrix Proteins in Human LV INF compared to LV and RV
Table S3 shows a comparison of the IR bands between RVs, LVs and LV INFs of the human hearts
compiled from IR spectra. Specific assignments of these bands were performed according to the
literature [5,6,30–37]. Most of the IR bands previously described in murine and porcine cardiac control
tissues are also present in the RV, LV, and LV INF of human hearts.
In agreement with the deep remodeling of infarcted tissue assessed by immunohistochemistry
(Figure 2A), FTIR analyses revealed the profound alteration of the IR band pattern at 1300–860 cm−1 in
the LV INF compared to the LV or RV samples (Figure 2B). A distinct feature of the collagen-specific
absorption band at 1338 cm−1 was found in the human LV INF sample but not in the RV or LV samples.
The indicator collagen/amide II (1338 cm−1/1540 cm−1), which reflects the content of structural proteins
related to the total proteins, was significantly increased in LV INF compared to LV (p = 0.023) and RV
(p = 0.023) (Figure 2C). The second derivative FTIR spectra (which allows increased resolution) showed
the exclusive presence of certain IR bands in LV INF at 1140 and 1095 cm−1 (Figure 2D, asterisks) in
the ν(C-O-C)/ν(C-OH) absorption zone, indicating deep alterations in oligosaccharides and also in
glycolipids, phospholipids, and nucleic acids in the infarcted area. In addition, intense absorptions at
1120 cm−1 (characteristic of ν(C-O) in lactate, polysaccharides, and glycogen), 1236 cm−1 (amide III),
and 1160 cm−1 (hydroxyproline residues, collagen specific) were detected in human LV INF compared
to LV and RV (Figure 2B,D, arrows). The increase of 1236 and 1160 cm−1 band absorptions could be
due to augmented collagen deposition in the infarcted zone, while that of 1120 cm−1 is associated with
elevated levels of lactate and/or polysaccharides in this zone (p = 0.047) (Figure 2E).
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As reported in Figure 3A, FTIR spectra corresponding to 1000–850 cm–1 where the DNA/RNA 
response prevails, showed differences between the three myocardial samples, which were 
quantified by the nucleic acid/protein indicator (band area ratio 974 cm–1/1540 cm–1, Figure 3B). 
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Figure 2. Immunohistochemical and FTIR analyses of fibrosis in human ventricle samples. Sirius Red
Staining was used to dist nguish t e collagen (in red) in the right ventricle (RV), left ven ricle (LV) and
infarcted left ventricle (LV INF) samples. Sc le Bar: 20 µm (A). Line graphs showing the 1350–1000 cm−1
averaged FTIR spectra of RV, LV, and LV INF (B). Boxplot analysis of the FTIR collage /protein indicator
(1338 cm−1/amide II) in the three groups (C). Line graphs showing the average second derivative spectra
in the 1370–1000 cm−1 region (D). Arrows indicate the bands altered in the LV INF samples. Asterisks
indicate the occurrence of new absorption bands in the LV INF samples. Boxplots showing lactate,
polysaccharide, and glycogen/protein indicator (1220 cm−1/amide II) in the three groups (n = 9/group)
(E). * p < 0.05. RV: right ventricle, LV: left ventricle, LV INF: infarcted left ventricle.
3.4. Identification of the Alterations in the FTIR Bands Corresponding to DNA Response in Human LV INF
Compared to LV and RV
As reported in Figure 3A, FTIR spectra corresponding to 1000–850 cm−1 where the DNA/RNA
response prevails, showed differences between the three myocardial samples, which were quantified
by the nucleic acid/protein indicator (band area ratio 974 cm−1/1540 cm−1, Figure 3B). There was
a significant decrease in the DNA/protein ratio from the right to left ischemic ventricles, reaching
significance in LV INF vs. LV (p = 0.0056) and RV (p = 0.0061) (Figure 3B).
This evolution is consistent with previous FTIR imaging results on infarcted myocardium,
indicating that nucleic acids are widespread in a normal myocardium but destroyed in an infarcted
myocardium [38]. All changes revealed the profound remodeling of the ECM in human infarcted tissue.
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Figure 3. FTIR analysis of the nucleic acids in the human ventricle samples. Line graphs showing
the 1000–850 cm−1 average FTIR spectra corresponding to the signal of nucleic acids in the RV, LV,
and LV INF samples (A). Boxplot analysis of nucleic acid/protein FITR indicator (974 cm−1/amide II)
(B) in the three groups (n = 9/group). * p < 0.05. RV: right ventricle, LV: left ventricle, LV INF: infarcted
left ventricle.
3.5. Study of the Hydric Respon e of Human RV, LV and LV INF
Representative DSC thermograms (normalized to the initial mass) of fresh human ventricles
corresponding to cooling from 20 to −100 ◦C and successive heating from −100 to 25 ◦C are reported in
Figure S8A. The cooling thermograms are characterized by an intense exothermic peak corresponding
to the crystallization of free water (namely, water not bound to hydrophilic components and able to form
ice). The onset temperature of the peak (Ton) is attributed to the transition temperature of this thermal
event. Th heating thermogra s are characterized by an ndothermic peak corresponding to th
melting f previously frozen water. Weak and multiple thermal eve ts are detectable in the (50–85 ◦C)
zone and attributed to the denaturation of cardiac muscle p ot ins, includi g myosin, sarcoplasmic
pr teins, colla en and actin as alre dy observed in a previous study [4]. There is a significant ecrease
in the temper ture of water crystallization Tc for LV INF compar d to LV (p = 0.044) (Figure S8B).
A similar trend is observed for the ic elting recorded in the heating scans. The increase in aqueous salt
concentrations could explain such a depr ssion of the melting/cr stallization temper ture. However,
the typical signature of aqueous salts, namely the eutectic phase transition at lower temper ture,
was not detected in the DSC thermograms of myoca dial samples. Since water crystallization and ice
melting are related to the pore size i porous [39] nd biological materials [40], the differences between
the infarcted and non-infarcted zones can be interpreted as changes in the archit cture associated with
a dec ease of t pore’s nomi al radius. Cardiac remodeling, including the replacement of myofibers
by collagen fibers marking a difference in the tissue architecture (pore size), could explain this peculiar
thermal behavior.
3.6. Study of the Associations between FITR Variables in Human RV, LV and LV INF
The FTIR spectra show that the CH2 bands (2921 cm−1 and 2850 cm−1) in the (CH2, CH3) stretching
zone (3000–2800 cm−1) are mainly associated with the lipid signature (Figure 4A) and the C=O
stretching zones of the ester carbonyl groups of phospholipids, triglycerides, and cholesteryl esters
(Figure 4B). There was an intensification of the lipid bands in the left infarcted ventricles, and a close
correlation (R = 1, p = 8.7 × 10−8) between the total lipid (2921–2850 cm−1/1540 cm−1) and the esterified
lipid (1745 cm−1/1540 cm−1) indicators (Figure 4C) in this zone. There were no correlations statistically
significant between tot l and esterified lipids in RV or LV (R = 0.93, p = 1; R = 0.89, p = 1, respectively),
suggest that most of the lipids re esterified in the infarc ed LV, but not in the RV or LV.
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Figure 4. FTIR analysis of the total and esterified lipids in the human ventricle samples. Line graphs 
showing the 3050–2800 cm–1 (A) and 1800–1700 cm–1 (B) average FTIR spectra corresponding to the 
signals of the total and esterified lipids, respectively, in right ventricle (RV), left ventricle (LV), and 
infarcted left ventricle (LV INF). (C) Correlation analysis between the FTIR indicators of the total and 
esterified lipids in LV INF. The correlation was studied with Pearson’s correlation, and the p-values 
were adjusted with Bonferroni’s correction. RV: right ventricle, LV: left ventricle, LV INF: infarcted 
left ventricle. 
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Lipidomic studies reflected deep lipid remodeling in the infarcted tissue. As visualized in the 
heatmap of Figure 5, cholesteryl ester and several sphingolipid species were significantly increased 
in LV INF compared to RV or LV, while most of the glycerophospholipid species were significantly 
decreased in the infarcted cardiac tissue. As shown in Table 2, SM 18:1 (14:0 and 14:1) and 16:1, 
dhSM 18:0 (16:0 and 18:0), and HexCer 18:1 species (16:0, 22:0, 24:0, 24:1) were significantly 
increased, while Cer 18:1 (18:0, 20:0, 20:1, 22:1 and 24:1) species were significantly decreased in the 
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36:5), and PG (34:1, 34:2), were significantly decreased in human infarcted tissue (Table 3). There 
were no significant differences in the PS, LPS, or LPC and the rest of glycerophospholipid species 
between LV INF and LV or RV (Table S5). Finally, among the neutral lipids, only cholesteryl esters 
were found to be significantly increased in the infarcted tissue (18:3) (Table 4). There were no 
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3.7. Identification of the Alterations in Sphingolipids, Glycerophospholipids and Neutral Lipids in Human LV
INF Compared to LV and RV
Lipidomic studies reflected deep lipid remodeling in the infarcted tissue. As visualized in the
heatmap of Figure 5, cholesteryl ester and several sphingolipid species were significantly increased
in LV INF compared to RV or LV, while most of the glycerophospholipid species were significantly
decreased in the infarcted cardiac tissue. As shown in Table 2, SM 18:1 (14:0 and 14:1) and 16:1,
dhSM 18:0 (16:0 and 18:0), and HexCer 18:1 species (16:0, 22:0, 24:0, 24:1) were significantly increased,
while Cer 18:1 (18:0, 20:0, 20:1, 22:1 and 24:1) species were significantly decreased in the LV infarcted
tissue (Table 2). There were no significant differences in CDH or the rest of the sphingolipid species
between LV INF and LV or RV (Table S4). Like Cer, the main glycerophospholipids, including PE (34:2,
36:4), LPE (18:2), PC (32:2, 34:1, 34:2, 34:3, 34:4, 36:2, 36:3, 36:5), and PG (34:1, 34:2), were significantly
decreased in human infarcted tissue (Table 3). There were no significant differences in the PS, LPS,
or LPC and the rest of glycerophospholipid species between LV INF and LV or RV (Table S5). Finally,
among the neutral lipids, only cholesteryl esters were found to be significantly increased in the infarcted
tissue (18:3) (Table 4). There were no differences in the highly abundant TAG species or minor FC
species between LV INF and LV or RV (Table S6).
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Figure 5. Lipidomic analysis of the human right ventricle, left ventricle and infarcted left ventricle. 
Heatmap of the nine human heart samples (in columns) based in the quantification of 40 differential 
lipid species (in rows) that exhibited statistically significant differences among right ventricle (RV), 
left ventricle (LV), and infarcted left ventricle (LV INF) samples. The heatmap colors represent a 
decimal logarithm of the quotient of the group mean and the mean value in all groups for each 
variable. Blue cells indicate values below the mean value of the variables in all groups, while red cells 
indicate values above the mean value of the variables in all groups. CE: cholesteryl esters, HexCer: 
hexosylceramide, SM: sphingomyelin, dhSM: dihydrosphingomyelin, CDH: ceramide dihexoside, 
TAG: triacylglycerols, PC: phosphatidylcholine, PE: phosphatidylethanolamine, LPE: 
lysophosphatidylethanolamine, Cer: ceramide, PG: phosphatidylglycerol. RV: right ventricle, LV: 
left ventricle, LV INF: infarcted left ventricle. 
Table 2. Sphingolipid species with differential concentrations in the infarcted left ventricle compared 
to left ventricle or right ventricle from human explanted ischemic hearts. 
Variable RV  LV  LV INF  p vs. LV pvs. RV 
SM(d18:1/14:0) 308.5 ± 77.4 309.5 ± 95.9 430.5 ± 95.3 0.024 0.055 
SM(d18:1/14:1) 3 ± 1.2 2.8 ± 1 3.9 ± 1.4 0.029 0.096 
SM(d18:1/16:1) 164 ± 39.5 160.1 ± 56.8 258.8 ± 105.8 0.029 0.041 
SM(d18:1/18:0) 1199.2 ± 156.3 1138.7 ± 128.5 1086.2 ± 142.7 0.485 0.038 
Total Cer 753 ± 261.6 592.7 ± 240.1 549.5 ± 179.1 0.932 0.044 
Cer(d18:1/18:0) 30.4 ± 13.5 22.9 ± 14.5 15 ± 4.9 0.115 0.029 
Cer(d18:1/18:1) 7.2 ± 2.3 5.2 ± 2 4.6 ± 1.1 0.456 0.006 
Cer(d18:1/20:0) 14.5 ± 3.6 11.1 ± 4 9.6 ± 2.8 0.457 0.01 
Cer(d18:1/20:1) 4.4 ± 0.8 3.4 ± 1.3 2.6 ± 0.6 0.13 0.006 
Cer(d18:1/22:1) 28.7 ± 22.9 20.2 ± 16.1 17.5 ± 20.1 0.804 0.018 
dhSM(d18:0/16:0) 179.4 ± 41.3 207.5 ± 91.7 226.4 ± 65 0.931 0.029 
dhSM(d18:1/18:0) 46.3 ± 13.4 49.5 ± 23.3 64.5 ± 16.3 0.174 0.041 
Figure 5. Lipidomic analysis of the human right ventricle, left ventricle and infarcted left ventricle.
Heatmap of the nine human heart samples (in columns) based in the quantification of 40 differential
lipid species (in rows) that exhibited statistically significant differences among right ventricle (RV),
left ventricle (LV), and infarcted left ventricle (LV INF) samples. The heatmap colors represent a decimal
logarithm of the quotient of the group mean and the mean value in all groups for each variable. Blue cells
indicate values below the mean value of the variables in all groups, while red cells indicate values
above the mean value of the variables i all groups. CE: cholester l esters, HexCer: hexosylceramide,
SM: sphingomyelin, dhSM: dihydros ingomyelin, CDH: ceramide di exoside, TAG: triacylglycerols,
PC: phos atidylcholine, PE: phosphatidylethanolamine, LPE: lysoph sphatidyletha olamine, Cer:
ceramide, PG: phosphatidylglycerol. RV: right ventricle, LV: left ventricle, LV INF: infarcted left ventricle.
Table 2. Sphingolipid species with differ ntial concentrati i the infarcted left ventri le compared
to left ven ricle or right ventricle from human explanted i ic hearts.
Variabl RV LV LV INF p vs. LV p vs. RV
SM(d18:1/14:0) 308.5 ± 77.4 309.5 ± 95.9 430.5 ± 95.3 0.024 0.055
SM(d18:1/14:1) 3 ± 1.2 2.8 ± 1 3.9 ± 1.4 0.029 0.096
SM(d18:1/16:1) 164 ± 39.5 160.1 ± 56.8 258.8 ± 105.8 0.029 0.041
SM(d18:1/18:0) 1199.2 ± 156.3 1138.7 ± 128.5 1086.2 ± 142.7 0.485 0.038
Total Cer 753 ± 261.6 592.7 ± 240.1 549.5 ± 179.1 0.932 0.044
Cer(d18:1/18:0) 30.4 ± 13.5 22.9 ± 14.5 15 ± 4.9 0.115 0.029
Cer(d18:1/18:1) 7.2 ± 2.3 5.2 ± 2 4.6 ± 1.1 0.456 0.006
Cer(d18:1/20:0) 14.5 ± 3.6 11.1 ± 4 9.6 ± 2.8 0.457 0.01
Cer(d18:1/20:1) 4.4 ± 0.8 3.4 ± 1.3 2.6 ± 0.6 0.13 0.006
Cer(d18:1/22:1) 28.7 ± 22.9 20.2 ± 16.1 17.5 ± 20.1 0.804 0.018
dhSM(d 8:0/16:0) 179.4 ± 41.3 207.5 ± 91.7 226.4 ± 65 0.931 0.029
dhSM(d18:1/18: 46.3 ± 13.4 49.5 ± 23 3 64.5 ± 16.3 0.174 0.041
Total HexCer 48.1 ± 26.6 63.9 ± 31.2 91.3 ± 36.6 0.114 0.006
HexCer(d18:1/16:0) 2.3 ± 1.5 3.2 ± 1.7 4.4 ± 3.1 0.474 0.023
HexCer(d18:1/22:0) 10.9 ± 5.8 16.1 ± 13.2 16 ± 5.6 1 0.012
HexCer(d18:1/24:0) 19.6 ± 10.4 25.3 ± 13.6 44.3 ± 25.1 0.127 0.018
HexCer(d18:1/24:1) 15.5 ± 10.5 20 ± 5.6 26.7 ± 13.5 0.102 0.006
Data are expressed as mean ± SD, n = 9 (RV, LV and LV INF). SM: sphingomyelin, Cer: Ceramide, dhSM:
dihydrosphingomyelin, HexCer: Hexosylceramide, SD: standard deviation, RV: right ventricle, LV: left ventricle, LV
INF: infarcted left ventricle.
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Table 3. Glycerophospholipid species with differential concentrations in the infarcted left ventricle
compared to left ventricle or right ventricle from human explanted ischemic hearts.
Variable RV LV LV INF p vs. LV p vs. RV
Total PC 54,624.9 ± 11408.6 56,737 ± 5670.8 48,392.9 ± 4893.7 0.012 0.335
PC(32:2) 342.5 ± 146.2 389.6 ± 115.9 221.1 ± 103.4 0.029 0.102
PC(34:1) 14,602.8 ± 2506.6 15,143.9 ± 1769.8 13,505.1 ± 1492.7 0.029 0.556
PC(34:2) 13,397 ± 2572.8 13,827.1 ± 1685 11,574.9 ± 1501.8 0.006 0.232
PC(34:3) 120.7 ± 54.3 133.2 ± 46.3 71.9 ± 21.8 0.012 0.049
PC(34:4) 100.7 ± 52.6 133.8 ± 67.5 64.7 ± 34.1 0.041 0.077
PC(36:2) 4753.8 ± 1047.4 4902.2 ± 444.3 4439.5 ± 328.1 0.025 0.698
PC(36:3) 3650 ± 1035 3884.2 ± 936.2 2866.5 ± 856.6 0.003 0.122
PC(36:5) 391.6 ± 437.5 376.8 ± 327.3 236.4 ± 269.4 0.041 0.069
Total PE 3502.5 ± 1052.4 3840.7 ± 914.1 2986.4 ± 769 0.004 0.285
PE(34:2) 203.1 ± 65.5 205.2 ± 47 144.1 ± 37.9 0.008 0.028
PE(36:4) 1014.5 ± 300.8 1309.3 ± 502.6 629.4 ± 269.1 0.011 0.036
LPE(18:2) 144.7 ± 60.3 142.7 ± 43.4 95 ± 30.3 0.006 0.052
Total PG 538.9 ± 135.4 581.8 ± 188.7 329.2 ± 152.5 0.045 0.041
PG(34:1) 483 ± 121.9 523 ± 176.8 300.9 ± 139.4 0.052 0.042
PG(34:2) 55.9 ± 20.6 58.8 ± 19.1 28.3 ± 14.9 0.028 0.047
Data are expressed as mean± SD, n = 9 (RV, LV and LV INF). PC: phosphatidylcholine, PE:phosphatidylethanolamine,
LPE: lysophosphatidylethanolamine, PG: phosphatidylglycerol, SD: standard deviation, RV: right ventricle, LV: left
ventricle, LV INF: infarcted left ventricle.
Table 4. Neutral lipid species with differential concentrations in the infarcted left ventricle compared
to left ventricle or right ventricle from human explanted ischemic hearts.
Variable RV LV LV INF p vs. LV p vs. RV
TAG(58:8) 2856 ± 1534.1 3364.8 ± 3160.3 1978.9 ± 1520.3 0.018 0.075
CE(18:3) 269.5 ± 248.3 352.3 ± 319.7 575.9 ± 583.5 0.239 0.018
Data are expressed as mean ± SD, n = 9 (RV, LV and LV INF). TAG: triacylglycerols, CE: cholesteryl esters, SD:
standard deviation, RV: right ventricle, LV: left ventricle, LV INF: infarcted left ventricle.
3.8. Study of the Association between FTIR and Lipidomic Variables in RV, LV and LV INF
As shown in Figure 6, biophysical studies revealed that ECM remodeling was closely associated
with lipid indicators, such as total lipids (2921–2850 cm−1) (R = 1, p = 1.6 × 10−8) (Figure 6A) and
esterified lipids (1745 cm−1/amide II) (R = 0.99, p = 9.3 × 10−7) (Figure 6B) specifically in LV INF.
In addition, other extracellular matrix markers such as lactate, polysaccharides, and glycogen, were
also closely associated with total lipids (R = 1, p = 3.6 × 10−11) (Figure 6C) and esterified lipids (R = 0.99,
p = 9.1 × 10−7) (Figure 6D) in the cardiac infarcted tissue. There was no significant correlation between
lipid and ECM remodeling FITR indicators in human RV (R = 0.54, p = 1) or LV (R = 0.68, p = 1).
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Figure 6. Correlation analysis of FTIR indicators of cardiac remodeling and lipids in the human 
heart. Correlation between the extracellular matrix (ECM) remodeling indicator and both total lipids 
(A) and esterified lipids (B), as well as between lactate, polysaccharide, and glycogen and both total 
lipids (C) and esterified lipids (D), in human infarcted left ventricle. The correlation was studied 
with Pearson’s correlation, and p values were adjusted with Bonferroni’s correction. LV INF: 
infarcted left ventricle. 
Figure 6. Correlation analysis of FTIR indicators of cardiac remodeling and lipids in the human heart.
Correlation between the extracellular matrix (ECM) remodeling indicator and both total lipids (A) and
esterified lipids (B), as well as between lactate, polysaccharide, and glycogen and both total lipids (C)
and esterified lipids (D), in human infarcted left ventricle. The correlation was studied with Pearson’s
correlation, and p values were adjusted with Bonferroni’s correction. LV INF: infarcted left ventricle.
4. Discussion
In this work, we used the FTIR spectrum to illustrate the overall variety of changes in proteins,
nucleic acids, and lipids that occur in human cardiac infarcted tissue. FTIR spectroscopy is very
sensitive to variations in cell metabolism, making it highly suitable for defining the structure in the
infarcted areas where the tissue has undergone strong cardiometabolic alterations primarily associated
with the process of ischemia [41].
The spectral signatures of the structural proteins of ECM and the myofibers in the human heart are
similar to those previously reported in murine [4] and porcine hearts [5]. One of the most significant
alterations observed in the FTIR spectra of human LV INF vs. LV or RV was a strong increase in the
1338 cm−1 band, which has been shown to be specific to collagen [6,25,36]. The utility of this particular
FTIR band to monitor the evolution of cardiac pathology and therapeutics was previously validated in
a rat MI model [6]. Another FTIR band that is deeply altered in the context of MI is the 974 cm−1 band
assigned to nucleic acids that, as expected, suffered a strong decline in LV INF compared to LV and RV.
These changes reflected a profound remodeling of the LV INF accompanying cardiomyocyte death
in the context of myocardial infarction and highlighted the potential of infrared markers to trace the
incidence of ischemia in cardiac remodeling.
The spectral signatures of lipids are also quasi-identical in the human heart to those in previous
murine [4] and pig [5] hearts. The vibrational response of the lipids is much more intense (for both
the ν(CH2) and ν(C=O) bands, corresponding to the total lipids and ester carbonyl groups of PL and
neutral lipids) in human than in murine or porcine ventricles. Lipidomic analysis of the human heart
revealed that the main lipids present are SM (d18:1) (88% of the total sphingolipids), PC (75% of the
total glycerophospholipids) and TAGs (97% of the total neutral lipids). There are few detailed lipidomic
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studies of ventricles and almost none on humans, likely due to the difficulty of obtaining human heart
samples. We found several species belonging to the sphingolipid, glycerophospholipid, and neutral
lipid families that were altered in LV INF but not in RV and LV. Most of the glycerophospholipids
decreased, while most of the sphingolipids and, specific species of cholesteryl esters increased in the
infarcted human cardiac tissue.
Between sphingolipids, the levels of several species of SM, dhSM, and HexCer were increased
in LV INF compared to LV or RV. The increase in the SM content of infarcted tissue found in the
present work seems to be coherent with the decreased sphingomyelinase (SMase) activity previously
described [42]. The increase in SM that we found in humans differs from the results showing
lower SM levels in the infarcted brains of in vivo models of ischemic stroke [43]. The cleavage of
SM by acid or neutral SMase results in the liberation of ceramide, a sphingolipid that acts as an
intracellular messenger regulating the activity of kinases, phosphatases, and transcription factors.
Ceramides were reported to be upregulated in the ischemic zones of the heart in several in vivo
models of ischemia/reperfusion [13,44,45]. This increase in ceramides after ischemia reperfusion
appears to be transient and linked with reperfusion injury, as shown in a model of ischemic-reperfused
myocardium in rats [42]. It has also been shown that the post-MI increase in cardiac ceramide is
not caused by increased SMase activity but instead by decreased ceramidase activity. In addition,
it has been recently demonstrated that a transient increase in acid ceramidase is sufficient to induce
cardioprotection post-MI [46]. Ceramide is utilized for the synthesis of other bioactive sphingolipids,
including sphingosine-1-phosphate, sphingosine, and the glycosphingolipids lactosylceramide and
hexosylceramide (HexCer). Here, several species of HexCer were found accumulated in human
infarcted hearts. Previous studies have reported the accumulation of HexCer in several organs from
in vivo models of aging [47,48]. Clinically, increased circulating levels of both SM and Cer have been
correlated with an increased risk of coronary artery disease [49,50].
Between glycerophospholipids, we found that the levels of the main PL, phosphatidylcholine
(PC), and other less abundant PLs, such as phosphatidylethanolamine (PE) and phosphatidylglycerol
(PG), were significantly decreased in LV INF compared to LV. These results are in agreement with
previous studies performed in in vivo MI models [16,17] showing a strong PL decay caused by
ischemia-induced phospholipolysis of the cardiomyocyte membranes. Increased phospholipolysis can
be caused, among other factors, by the upregulatory effect of hypoxia on phospholipase activity [51,52].
Unbalanced levels of anionic phospholipids such as PG seem to have harmful consequences for
mitochondrial morphology and function. PG plays a pivotal role in the formation of cardiolipin, which is
essential in the control of mitochondrial inflammation and oxidative stress [53,54], and respiratory
activity [54]. In this study, we found a significant loss of PG that could, indeed, contribute to a
serious decrease in mitochondrial oxidative metabolism in infarcted tissue. The strong decrease in
mitochondrial respiratory activity combined with acute phospholipolysis, which actively generates
fatty acids [16,17], could be a determinant for increased FA esterification. An additional source of
esterified lipids in the infarcted tissue is circulating lipoproteins. Several groups, including ours,
have reported the upregulatory effect of hypoxia/ischemia on lipoprotein receptors such as Very
low-density lipoprotein receptor VLDLR and Low-density lipoprotein receptor related-protein 1 LRP1,
which bind and internalize lipoproteins such as Very low-density lipoprotein (VLDL) and Low-density
lipoprotein (LDL) (lipoproteins highly enriched in cholesteryl esters) [11–13,55,56]. Here, the close
correlation between esterified lipids and remodeling in the human infarcted tissue pointed to FTIR
lipid indicators as potential biomarkers of remodeling, at least in the context of ischemia. Previous
studies from our group demonstrated that the levels of intracellular esterified lipids in cardiomyocytes
determine the structural and physical characteristics of secreted tropoelastin through an increase in
cathepsin S mature protein levels [57]. The intracellular esterified lipids stored in lipid droplets are the
subject of an intense debate over their potential beneficial/harmful effects on cell functionality [58].
The differential implications of triglyceride and cholesteryl ester proportions in these lipid droplets are
also under discussion [59].
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5. Conclusions
As a general conclusion, FTIR studies showed that human cardiac infarcted tissue suffers deep
alterations in proteins, nucleic acids, and—especially—lipids. Liquid chromatography coupled to
high-resolution mass spectrometry (LC–HRMS) revealed the strong lipid remodeling that results in
reduced levels of PC, PE, LPE and PG and increased levels of SM, HexCer and cholesteryl esters
in human cardiac infarcted tissue. We found a strong and positive association between esterified
lipids and adverse cardiac remodeling in the context of human cardiac remodeling post-MI. The
specific conclusions are that (i) there are deep alterations of the FTIR bands related to myofibers and
structural extracellular matrix proteins in human LV INF compared to LV and RV, (ii) there are strong
differences in the FTIR spectra corresponding to DNA responses in human LV INF compared to RV
and LV, (iii) there is a differential hydric response of human LV INF compared to RV and LV, (iv) FTIR
combined with lipidomic studies showed a strong intensification of lipids, particularly esterified lipids
concomitantly with deep phospholipid remodeling in human infarcted hearts, and (v) esterified lipids
are closely related with adverse cardiac remodeling in human infarcted heart. Thus, we have shown
that FTIR lipid indicators are potential biomarkers of cardiac remodeling and validated certain lipid
species as crucial in human pathological ventricular remodeling post-MI.
Limitations of This Study: The main limitation of this study is the low number of patients included due to the
difficulty of (i) obtaining samples from ischemic cardiomyopathy patients and (ii) performing biophysical and
lipidomic studies on an elevated number of series. However, great differences in some variables were found
between ventricle samples, as well as strong correlations between variables. There was also a high correlation
between ECM remodeling indicators and the total and esterified lipids in LV INF. Furthermore, we have obtained
relatively high values of statistical power (between 0.64–0.98), despite the low number of samples, due to the big
differences in some variables between the ventricles. Regardless, more studies are needed to confirm our results
and provide higher statistical power. We also consider, as limitation of this study, the impossibility to characterize
the infarcted right ventricle due to the low prevalence and diagnose of this entity. Finally, we could not assess
the levels of cardiolipin, a crucial lipid in cardiovascular disease, due to the technical unavailability to perform
this analysis.
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